Literature DB >> 6861094

Liposarcoma occurring in children. An analysis of 17 cases and review of the literature.

B M Shmookler, F M Enzinger.   

Abstract

Liposarcoma, one of the most common malignant mesenchymal neoplasms affecting adults, has rarely been documented to arise in children. Therefore, in this retrospective study, the clinicopathologic features of 17 liposarcomas retrieved from the files of the Armed Forces Institute of Pathology (AFIP) which occurred in patients between the ages of eight months and 15 years were analyzed. In contrast to the slight male prevalence verified in most studies of adult liposarcoma, this group of 17 cases disclosed a distinct female majority (65%). The tumor had a predilection for the lower extremity (41%), particularly the thigh; the remaining examples, which included cases from the neck, back, axilla, buttock, and forearm, reflected a seemingly random anatomic distribution. The retroperitoneum, a very common primary location for adult liposarcoma, accounted for only one example in the group. The histologic variants of liposarcoma coincided with the types delineated in most generally accepted classifications employed for liposarcoma in adults, but their distribution varied considerably from that found in most extensive series of adult liposarcomas. Specifically, there were 13 myxoid liposarcomas, two well-differentiated liposarcomas, and one each of the round cell and mixed variants. Follow-up information, obtained for 15 cases, revealed local recurrence in three patients, one of whom eventually died as a result of direct tumor extension into the pleural cavity.

Entities:  

Mesh:

Year:  1983        PMID: 6861094     DOI: 10.1002/1097-0142(19830801)52:3<567::aid-cncr2820520332>3.0.co;2-4

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  19 in total

Review 1.  MR imaging of soft tissue tumors and tumor-like lesions.

Authors:  Tal Laor
Journal:  Pediatr Radiol       Date:  2003-12-12

2.  Radiological-pathological correlation in lipoblastoma and lipoblastomatosis.

Authors:  Shruti Moholkar; Neil J Sebire; Derek J Roebuck
Journal:  Pediatr Radiol       Date:  2006-06-15

3.  Lipoblastoma in a 14-year-old boy: report of a case.

Authors:  K Y Kok; P U Telesinghe
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

4.  Liposarcoma in children and young adults: a clinicopathologic and molecular study of 23 cases in one of the largest institutions of China.

Authors:  Ran Peng; Nan Li; Ting Lan; Huijiao Chen; Tianhai Du; Xin He; Min Chen; You Xie; Zhang Zhang; Wei Zhao; Hongying Zhang
Journal:  Virchows Arch       Date:  2021-03-18       Impact factor: 4.064

Review 5.  Benign fatty tumors: classification, clinical course, imaging appearance, and treatment.

Authors:  Laura W Bancroft; Mark J Kransdorf; Jeffrey J Peterson; Mary I O'Connor
Journal:  Skeletal Radiol       Date:  2006-08-23       Impact factor: 2.199

6.  Pleomorphic myxoid liposarcoma in an adolescent with Li-Fraumeni syndrome.

Authors:  Tiffany J Sinclair; Chad M Thorson; Elysia Alvarez; Serena Tan; Sheri L Spunt; Stephanie D Chao
Journal:  Pediatr Surg Int       Date:  2017-02-03       Impact factor: 1.827

7.  Primary liposarcoma of the lung in a young woman.

Authors:  F Ruiz-Palomo; J L Calleja; L Fogue
Journal:  Thorax       Date:  1990-04       Impact factor: 9.139

8.  [liposarcoma. Aspects of pathomorphology--an analysis of 209 tumos].

Authors:  C Kuhnen; M Lehnhardt; H U Steinau; K-M Müller
Journal:  Chirurg       Date:  2004-12       Impact factor: 0.955

Review 9.  Perineal lipoblastoma: a case report and review of literature.

Authors:  Qiang Liu; Zheng Xu; Shunbao Mao; Rongyao Zeng; Wenyou Chen; Qiang Lu; Yihe Guo; Jing Liu
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15

Review 10.  Malignant fatty tumors: classification, clinical course, imaging appearance and treatment.

Authors:  Jeffrey J Peterson; Mark J Kransdorf; Laura W Bancroft; Mary I O'Connor
Journal:  Skeletal Radiol       Date:  2003-06-11       Impact factor: 2.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.